These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 21898680)
1. Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Duijvestein M; Wildenberg ME; Welling MM; Hennink S; Molendijk I; van Zuylen VL; Bosse T; Vos AC; de Jonge-Muller ES; Roelofs H; van der Weerd L; Verspaget HW; Fibbe WE; te Velde AA; van den Brink GR; Hommes DW Stem Cells; 2011 Oct; 29(10):1549-58. PubMed ID: 21898680 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses. Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467 [TBL] [Abstract][Full Text] [Related]
3. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis. Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088 [TBL] [Abstract][Full Text] [Related]
4. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis. Liang L; Dong C; Chen X; Fang Z; Xu J; Liu M; Zhang X; Gu DS; Wang D; Du W; Zhu D; Han ZC Cell Transplant; 2011; 20(9):1395-408. PubMed ID: 21396175 [TBL] [Abstract][Full Text] [Related]
5. Gene delivery with IFN-γ-expression plasmids enhances the therapeutic effects of MSCs on DSS-induced mouse colitis. Chen Y; Song Y; Miao H; Xu Y; Lv M; Wang T; Hou Y Inflamm Res; 2015 Sep; 64(9):671-81. PubMed ID: 26153869 [TBL] [Abstract][Full Text] [Related]
6. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2. Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922 [TBL] [Abstract][Full Text] [Related]
7. The therapeutic efficacy of mesenchymal stromal cells on experimental colitis was improved by the IFN-γ and poly(I:C) priming through promoting the expression of indoleamine 2,3-dioxygenase. Lim JY; Kim BS; Ryu DB; Kim TW; Park G; Min CK Stem Cell Res Ther; 2021 Jan; 12(1):37. PubMed ID: 33413597 [TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicles Secreted by Mesenchymal Stromal Cells Exert Opposite Effects to Their Cells of Origin in Murine Sodium Dextran Sulfate-Induced Colitis. Tolomeo AM; Castagliuolo I; Piccoli M; Grassi M; Magarotto F; De Lazzari G; Malvicini R; Caicci F; Franzin C; Scarpa M; Macchi V; De Caro R; Angriman I; Viola A; Porzionato A; Pozzobon M; Muraca M Front Immunol; 2021; 12():627605. PubMed ID: 33927713 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease. Xie M; Qin H; Luo Q; He X; He X; Lan P; Lian L Dig Dis Sci; 2017 Jan; 62(1):115-123. PubMed ID: 27107864 [TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis. Castelo-Branco MT; Soares ID; Lopes DV; Buongusto F; Martinusso CA; do Rosario A; Souza SA; Gutfilen B; Fonseca LM; Elia C; Madi K; Schanaider A; Rossi MI; Souza HS PLoS One; 2012; 7(3):e33360. PubMed ID: 22432015 [TBL] [Abstract][Full Text] [Related]
11. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu. Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS Front Immunol; 2018; 9():1078. PubMed ID: 29892282 [TBL] [Abstract][Full Text] [Related]
12. Endoscopic Administration of Mesenchymal Stromal Cells Reduces Inflammation in Experimental Colitis. Barnhoorn M; de Jonge-Muller E; Molendijk I; van Gulijk M; Lebbink O; Janson S; Schoonderwoerd M; van der Helm D; van der Meulen-de Jong A; Hawinkels L; Verspaget H Inflamm Bowel Dis; 2018 Jul; 24(8):1755-1767. PubMed ID: 29796655 [TBL] [Abstract][Full Text] [Related]
13. hUC-MSCs therapy for Crohn's disease: efficacy in TNBS-induced colitis in rats and pilot clinical study. Sun Q; Li S; Lin R; Zhao G; Lu J; Liu B; Hu M; Wang W; Yang X; Wei Y; Jia W; Hu Y; Zhang W; Zhu J; Cui D; Zhong L EBioMedicine; 2024 May; 103():105128. PubMed ID: 38653187 [TBL] [Abstract][Full Text] [Related]
14. Interferon-γ-mediated secretion of tryptophanyl-tRNA synthetases has a role in protection of human umbilical cord blood-derived mesenchymal stem cells against experimental colitis. Kang I; Lee BC; Lee JY; Kim JJ; Lee SE; Shin N; Choi SW; Kang KS BMB Rep; 2019 May; 52(5):318-323. PubMed ID: 30293546 [TBL] [Abstract][Full Text] [Related]
15. Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens. Li X; Wang Q; Ding L; Wang YX; Zhao ZD; Mao N; Wu CT; Wang H; Zhu H; Ning SB Stem Cell Res Ther; 2019 Aug; 10(1):267. PubMed ID: 31443680 [TBL] [Abstract][Full Text] [Related]
16. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis? Gonçalves Fda C; Schneider N; Pinto FO; Meyer FS; Visioli F; Pfaffenseller B; Lopez PL; Passos EP; Cirne-Lima EO; Meurer L; Paz AH World J Gastroenterol; 2014 Dec; 20(48):18228-39. PubMed ID: 25561790 [TBL] [Abstract][Full Text] [Related]
17. Regulatory Dendritic Cells Induced by Mesenchymal Stem Cells Ameliorate Dextran Sodium Sulfate-Induced Chronic Colitis in Mice. Jo H; Eom YW; Kim HS; Park HJ; Kim HM; Cho MY Gut Liver; 2018 Nov; 12(6):664-673. PubMed ID: 29938461 [TBL] [Abstract][Full Text] [Related]
18. Embryonic stem cell-derived mesenchymal stem cells promote colon epithelial integrity and regeneration by elevating circulating IGF-1 in colitis mice. Xu J; Wang X; Chen J; Chen S; Li Z; Liu H; Bai Y; Zhi F Theranostics; 2020; 10(26):12204-12222. PubMed ID: 33204338 [No Abstract] [Full Text] [Related]
19. Intraluminal Injection of Mesenchymal Stromal Cells in Spheroids Attenuates Experimental Colitis. Molendijk I; Barnhoorn MC; de Jonge-Muller ES; Mieremet-Ooms MA; van der Reijden JJ; van der Helm D; Hommes DW; van der Meulen-de Jong AE; Verspaget HW J Crohns Colitis; 2016 Aug; 10(8):953-64. PubMed ID: 26896084 [TBL] [Abstract][Full Text] [Related]
20. TLR3 preconditioning enhances the therapeutic efficacy of umbilical cord mesenchymal stem cells in TNBS-induced colitis via the TLR3-Jagged-1-Notch-1 pathway. Qiu Y; Guo J; Mao R; Chao K; Chen BL; He Y; Zeng ZR; Zhang SH; Chen MH Mucosal Immunol; 2017 May; 10(3):727-742. PubMed ID: 27649928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]